Eric Raymond
MD PhD
Professor
👥Biography 个人简介
Eric Raymond at Lariboisiere led the pivotal phase III trial of sunitinib in pancreatic neuroendocrine tumors — establishing sunitinib as an approved treatment for progressive, well-differentiated pNETs alongside everolimus. His clinical research on anti-VEGF/VEGFR approaches in NETs and his contributions to European NET clinical trial development have been important for this specialty.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Eric Raymond 的研究动态
Follow Eric Raymond's research updates
留下邮箱，当我们发布与 Eric Raymond（Hopital Lariboisiere）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment